Ruptured thoracoabdominal aortic aneurysm treatment in the United States: 1988 to 1998  by Cowan, John A et al.
Ruptured thoracoabdominal aortic aneurysm
treatment in the United States: 1988 to 1998
John A. Cowan, Jr, MD, Justin B. Dimick, MD, Reid M. Wainess, BS, Peter K. Henke, MD, James C.
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Objective: Thoracoabdominal aortic aneurysm (TAAA) rupture usually results in death. The outcome remains poor for
patients who reach the operating room. The objective of this investigation was to define contemporary surgical experience
with ruptured TAAA in the United States.
Patients and methods: Clinical data derived from the Nationwide Inpatient Sample on patients who underwent repair of
a ruptured TAAA from 1988 to 1998 were analyzed. Age, sex, race, nature of admission, comorbid conditions, and
provider volume were abstracted from the database. In-hospital mortality, postoperative complications, and length of
stay were the principal outcome measures.
Results: Three hundred twenty-one patients were identified for the study. Mean age was 71.5 years; men outnumbered
women (63% vs 37%). Crude overall surgical mortality was 53.8% and did not improve over time. Operative mortality was
most likely (51%) to occur within the first 24 hours postoperatively. Median length of stay for surviving patients was 16
days. Renal failure (28%) and cardiac complications (18%) were the most common complications. In a logistic regression
model, age greater than 77 years was predictive of death (odds ratio [OR], 2.5; P  .005), and nonwhite race appeared
protective (OR, 0.53; P  .013).
Conclusions:Mortality after surgical treatment of ruptured TAAA is high. Surviving patients experience many postoper-
ative complications and have lengthy hospital stays. Given the lack of significant improvement in contemporary surgical
practice, new techniques of repair deserve the attention of clinicians. (J Vasc Surg 2003;38:319-22.)
Thoracoabdominal aortic aneurysm (TAAA) is rela-
tively uncommon. Rupture is the most lethal complication
in untreated cases.1 Operative mortality ranges from 17% to
67% for ruptured TAAA, depending on whether the rup-
ture is contained or free.2-7 These data typically derive from
a subanalysis of a single institution’s total TAAA experience
and may not reflect the true demographics, mortality, and
length of stay (LOS) for surgically treated ruptured TAAA
in the United States. The objective of the present study was
to describe the experience with surgically treated ruptured
TAAA over 11 years in a nationally representative sample.
METHODS
Data source. Clinical data for patients undergoing
repair of ruptured TAAA from 1988 to 1998 were derived
from the Nationwide Inpatient Sample (NIS),8 a 20% ran-
dom sample of US hospitals stratified by geographic region,
teaching status, hospital size, and other characteristics.
Participating hospitals provide 100% of their discharge
abstracts for a particular calendar year. The database is
maintained by the Agency for Health Care Research and
Quality as part of the Healthcare Cost and Utilization
Project.
Overall, 2185 patients who underwent repair of TAAA
were identified with the International Classification of Dis-
eases-ninth revision-Clinical Modification (ICD-9-CM)
codes for resection and replacement of the abdominal aorta
(ICD-9-CM, 384.4) and resection and replacement of the
thoracic aorta (ICD-9-CM, 384.5).9 Included in this
group were 321 patients identified as having TAAA rupture
with one of the following diagnostic codes: 441.1, rup-
tured thoracic aneurysm; 441.3, ruptured abdominal aortic
aneurysm; 441.5, ruptured abdominal aortic aneurysm, not
otherwise specified; or 441.6, ruptured thoracoabdominal
aortic aneurysm.
Information abstracted from the database included age,
gender, race, nature of admission, comorbid conditions, a
unique hospital identifier, vital status at discharge, LOS,
and postoperative complications. Patient age was classified
by quartiles for the purpose of comparison and defined as
less than 68 years, 68 to 72 years, 73 to 77 years, and
greater than 77 years. Race was categorized as white or
nonwhite. Comorbid conditions were determined with the
Romano modification of the Charlson comorbidity in-
dex.10,11 Total TAAA repair volume and total AAA volume
variables for each hospital were created with terciles, which
were calculated on a yearly basis. For TAAA repair, hospital
volume was considered low (median, 1 case per year; range,
1-3 cases per year), medium (median, 4 cases per year;
range, 2-6 cases per year), or high (median, 12 cases per
year; range, 6-31 cases per year). For AAA repair, hospital
volume was considered low (median, 2 cases per year;
range, 1-4 cases per year), medium (median, 9 cases per
From the Department of Surgery, Section of Vascular Surgery, University of
Michigan Medical Center, Ann Arbor, Mich.
Competition of interest: none.
Reprint requests: Gilbert R. Upchurch, Jr, MD, Section of Vascular Surgery,
1500 E Medical Center Dr, Ann Arbor, MI 48109-0329. (e-mail:
riversu@umich.edu).
Published online May 29, 2003.
Copyright © 2003 by The Society for Vascular Surgery and The American
Association for Vascular Surgery.
0741-5214/2003/$30.00  0
doi:10.1016/S0741-5214(03)00227-1
319
year; range, 5-15 cases per year), or high (median, 30 cases
per year; range, 16-191 cases per year). The overlap in
range is a result of annual variation in absolute number of
TAAA operations performed during the study period.
Outcome variables. In-hospital postoperative mortal-
ity was the primary outcome variable. Secondary outcome
measures were postoperative complications and LOS. The
array of postoperative complications was tabulated with
ICD-9-CM codes 996.0 to 999.0. Specific cardiac (997.1),
pulmonary (997.3), and hemorrhagic (998.1, 998.11)
complications, acute renal failure (584.0, 584.6, 584.8,
584.9, 788.5, and paralysis (344.1, 344.9) were also ana-
lyzed. Overall LOS was adjusted to reflect postoperative
hospital stay.
Statistical analysis. Descriptive statistical analysis was
performed on demographic variables. Descriptive and uni-
variate comparisons were performed on specific demo-
graphic and outcomes variables with analysis of variance, X2
test, and Mantel-Haenszel common odds ratio where ap-
propriate. Stepwise binary logistic regression (inclusion
threshold, P  .1) of in-hospital mortality was used to
determine independent risk factors. The multivariate
model of mortality was tested for goodness of fit according
to the Hosmer-Lemeshow method.12 P  .05 was consid-
ered statistically significant in all final analyses. SPSS version
11.0 (SPSS, Chicago, Ill) was used for all statistical analyses
and graphing.
RESULTS
Mean age of the 321 patients was 71.5 (SD  8.8;
range, 24-93 years) years. Men outnumbered women (63%
vs 37%). Sixty-six percent of patients were white. Chronic
obstructive pulmonary disease was the most common co-
morbid condition (16.1%). Diabetes mellitus (4.4%), pre-
vious myocardial infarction (3.7%), and coexisting renal
disease (0.9%) were less common. No significant differ-
ences were observed in comorbidity rates on the basis of
patient age. Crude overall mortality rate was 53.8%, with no
measurable improvement during the study (Fig 1). Mortal-
ity increased with increasing patient age (Fig 2).
The majority of patients (51.7%) had at least one post-
operative complication (Table I). Acute renal failure
(28.0%) and cardiac-related events (18.1%) were the most
common complications. All postoperative complications,
with the exception of pulmonary complications and para-
plegia, increased risk for death. For surviving patients,
median LOS was 16 days (interquartile range, 25th-75th
percentile, 10-28 days), and for nonsurvivors was 1 day
(interquartile range, 25th-75th percentile, 0-8 days). More
than half (51.2%) of all deaths occurred within 24 hours
after surgery.
The logistic regression model for mortality was reveal-
ing (Table II). The Hosmer-Lemeshow X2 equaled 5.6
(P  .692), suggesting a good fit. Patient age greater than
77 years was predictive of death (odds ratio [OR], 2.5; P
.005), and nonwhite race appeared protective (OR, 0.53; P
 .013). Female gender (OR, 1.5; P  .106) was sugges-
tive of increased mortality. The more contemporary period
of the study (1994-1998) did not result in decreased risk
for death. No significant relationship between hospital total
TAAA surgical volume or total AAA volume (either low,
medium, or high) and mortality after surgery to treat
ruptured TAAA could be demonstrated with univariate
analysis (P  .398 and P  .375, respectively).
Fig 1. In-hospital postoperative mortality rates for surgically
treated ruptured thoracoabdominal aortic aneurysm from 1988 to
1998 in the United States. There was no significant change (P 
.74) in mortality rate during the study period, the mean being
53.8%.
Fig 2. Age-related postoperative mortality for surgically treated
ruptured thoracoabdominal aortic aneurysm. Older age groups,
determined with quartiles, had greater mortality rates (P  .023,
Pearson X2 test). Vertical lines represent 95% confidence interval
around the mean.
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DISCUSSION
Ruptured TAAA comprise approximately 15% of all
surgically treated TAAA in the United States. In the present
study, postoperative mortality rates ranged from 40% to
70%, with no evidence of improvement in contemporary
practice. More than half of these patients died within the
first 24 hours postoperatively. This suggests that little head-
way is being made nationally with use of current surgical
strategies.
Postoperative outcome from the majority of large insti-
tutions with high-volume elective TAAA practices report
similar mortality rates as those in this nationally based
study. Cina et al5 reported 64% mortality in treating rup-
tured TAAA, while reporting excellent elective TAAA mor-
tality rates. In a 10-year cohort study, Bradbury et al2
reported 60% mortality in their ruptured TAAA experience.
Similar mortality was observed in an 8-year cohort study by
Velazquez et al,3 who demonstrated 67% (free rupture) and
50% (immediate presentation) mortality rates accompany-
ing repair of ruptured TAAA.
A few select institutions have reported lower mortality
in treating ruptured TAAA. Cambria et al,4 in a 15-year
experience with 337 TAAA treated by a single surgeon, of
which 13.6% ruptured, reported postoperative mortality of
only 17%. Lemaire et al7 reported 17% mortality among 76
patients undergoing surgery to treat ruptured TAAA. The
latter authors found no relationship between age and out-
come, contrary to the results in the present study. It is
unclear how selection bias or referral patterns of contained
ruptures may skew these results. Regardless, these superior
results clearly represent a significant investment of talent
and resources in the surgical treatment of TAAA and may
provide the impetus to refer patients in the elective setting
to centers that demonstrate similar results. However, in the
case of ruptured TAAA this option may not exist, and
therefore alternative approaches for managing these pa-
tients should be explored.
The efficacy of endovascular stent grafting of ruptured
TAAA has been documented in case reports and small
series. Chuter et al13 described successful deployment of a
stent graft specially designed for TAAA in a 76-year-old
patient with a contained rupture. The patient survived;
however, on postoperative day 2 paraplegia developed. No
immediate deaths or paraplegia were reported after similar
therapy in the small series of Doss et al14 (n 3) or Morgan
et al15 (n  4) with contained ruptures. Alric et al16
reported one post-procedure death in 10 patients undergo-
ing endovascular intervention (seven with aneurysm dis-
ease) who had ruptured TAAA at presentation. These re-
ports suggest that incorporating endovascular techniques
may provide a means of improving the otherwise excessive
mortality rate accompanying open surgical repair of rup-
tured TAAA.
This review of a national experience has certain limita-
tions. The nature of the NIS administrative data precludes
analysis of specific physiologic variables (eg, hemodynamic
status, blood loss, creatinine concentration), operative vari-
ables (eg, thoracotomy or laparotomy, circulatory bypass),
and anatomic variables (eg, aneurysm type, exact location,
size) that may influence outcome. Furthermore, the post-
operative complications rely on secondary diagnostic codes
that may not have been coded with 100% accuracy. For
example, this may explain the unusually low incidence of
paraplegia. That pulmonary complications were protective
against death may simply represent the decrease in mortal-
ity of those surviving beyond the first few postoperative
days and therefore surviving long enough to manifest pul-
monary complications. The comorbidity codes used may
have been underreported and do not describe the severity
of a particular condition or any therapeutic interventions
that may modify the diagnosis. For example, a patient
coded as having a history of myocardial infarction may have
had a single event or multiple events and may or may not
have undergone coronary artery angioplasty, stenting, or
bypass grafting. Furthermore, it does not measure the
incidence of coronary artery disease in the population.
Nevertheless surgically treated ruptured TAAA are as-
sociated with extremely high, and often early, postoperative
mortality in the United States. Given the lack of significant
improvement in contemporary surgical practice, new tech-
niques of repair deserve the attention of clinicians.
Table I. Postoperative complications associated with
surgically treated ruptured thoracoabdominal aortic
aneurysm in the United States: from 1988-1998
Complication
Rate
(%)
For mortality
odds ratio* P
Acute renal failure 28.0 1.6 .063
Cardiac 18.1 1.6 .097
Pulmonary 12.7 0.20 .001
Hemorrhage 10.9 1.5 .262
Paraplegia 3.4 0.70 .570
Any complication 51.7 1.1
*Mantel-Haenszel common odds ratio estimate.
Table II. Binary logistic regression model for
postoperative mortality for ruptured thoracoabdominal
aortic aneurysm
Risk factor
Odds
ratio*
95%
confidence
interval P
Age (y)†
77 2.5 1.3, 4.9 .005
73–77 1.5 0.79, 2.7 .230
68–72 1.8 0.94, 3.4 .074
Female gender 1.5 0.92, 2.4 .106
Chronic obstructive pulmonary
disease
0.94 0.51, 1.8 .856
Time period, 1994–1998‡ 0.74 0.44, 1.23 .252
Nonwhite race 0.53 0.32, 0.88 .13
*Odds ratio great than 1 represents an increased risk for death.
†Odds ratios compared with 68 years of age.
‡Odds ratio compared with the period 1988–1993.
JOURNAL OF VASCULAR SURGERY
Volume 38, Number 2 Cowan et al 321
REFERENCES
1. Crawford ES, DeNatale RW. Thoracoabdominal aortic aneurysm: ob-
servations regarding the natural course of the disease. J Vasc Surg
1986;3:578-82.
2. Bradbury AW, Bulstrode NW, Gilling-Smith G, Stansby G, Mansfield
AO, Wolfe JH. Repair of ruptured thoracoabdominal aortic aneurysm is
worthwhile in selected cases. Eur J Vasc Endovasc Surg 1999;17:160-5.
3. Velazquez OC, Bavaria JE, Pochettino A, Carpenter JP. Emergency
repair of thoracoabdominal aortic aneurysms with immediate presenta-
tion. J Vasc Surg 1999;30:996-1003.
4. Cambria RP, Clouse WD, Davison JK, Dunn PF, Corey M, Dorer D.
Thoracoabdominal aneurysm repair: results with 337 operations per-
formed over a 15-year interval. Ann Surg 2002;236:471-9.
5. Cina CS, Lagana A, Bruin G, Ricci C, Doobay B, Tittley J, et al.
Thoracoabdominal aortic aneurysm repair: a prospective cohort study of
121 cases. Ann Vasc Surg 2002;16:631-8.
6. Lewis ME, Ranasinghe AM, Revell MP, Bonser RS. Surgical repair of
ruptured thoracic and thoracoabdominal aortic aneurysms. Br J Surg
2002;89:442-5.
7. Lemaire SA, Rice DC, Schmittling ZC, Coselli JS. Emergency surgery
for thoracoabdominal aortic aneurysms with acute presentation. J Vasc
Surg 2002;35:1171-8.
8. Healthcare Cost and Utilization Project. Nationwide Inpatient Sample,
Releases 1-6. Rockville, Md: Agency for Health Care Research and
Quality; 1988-1998.
9. Public Health Service HCFA. International classification of diseases, 9th
revision. Clinical modification (ICD-9-CM). Washington, DC: US
Department of Health and Human Services; 1991.
10. Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method for
classifying prognostic comorbidity in longitudinal studies: development
and variation. J Chronic Dis 1987;40:373-83.
11. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index
for use with ICD-9-CM administrative data: differing perspectives.
J Clin Epidemiol 1993;46:1075-9.
12. Lemeshow S, Hosmer DW Jr. A review of goodness of fit statistics for
use in the development of logistic regression models. Am J Epidemiol
1982;115:92-106.
13. Chuter TA, Gordon RL, Reilly LM, Goodman JD, Messina LM. An
endovascular system for thoracoabdominal aortic aneurysm repair. J
Endovasc Ther 2001;8:25-33.
14. Doss M, Martens S, Hemmer W. Emergency endovascular interven-
tions for ruptured thoracic and abdominal aortic aneurysms. Am Heart J
2002;144:544-8.
15. Morgan R, Loosemore T, Belli AM. Endovascular repair of contained
rupture of the thoracic aorta. Cardiovasc Intervent Radiol 2002;25:291-4.
16. Alric P, Berthet JP, Branchereau P, Veerapen R, Marty-Ane CH.
Endovascular repair for acute rupture of the descending thoracic aorta.
J Endovasc Ther 2002;9(suppl 2):II51-9.
Submitted Dec 12, 2002; accepted Feb 4, 2003.
PREVIEW UPCOMING ARTICLES ON THE WEB
Articles that have been accepted for publication and copyedited can often be read on the Journal Web site 1 or 2
months before publication in print. The full text of the article with all figures, references, and reference links to
PubMed are available. The articles can be printed in their final format using the PDF link.
JOURNAL OF VASCULAR SURGERY
August 2003322 Cowan et al
